Nectar Lifesciences (INR)39.5-0.6 (-1.6%)
Exchange ScripsBSE532649NSENECLIFEISININE023H01027
Indicators | Value | Signal |
---|---|---|
5-DMA | 41.01 | Bearish |
10-DMA | 40.76 | Bearish |
20-DMA | 37.39 | Bullish |
50-DMA | 36.39 | Bullish |
100-DMA | 38.18 | Bullish |
200-DMA | 35.35 | Bullish |
Field | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sep-2023 |
---|---|---|---|---|---|
Promoters | 2 | 2 | 2 | 2 | 2 |
Foreign Investors | --- | --- | --- | --- | --- |
Domestic Investors | 2 | 2 | 2 | 2 | 2 |
Public Investors | 66738 | 58227 | 59943 | 60758 | 60280 |
Government | 1 | 1 | 1 | 1 | 1 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Other Income | 243 | 531 | 113 | 114 |
Operating Profit | 1759 | 1061 | 1699 | 1128 |
Interest | 969 | 894 | 788 | 1120 |
Depreciation | 607 | 591 | 570 | 603 |
Profit Before Tax | 183 | -424 | 341 | -848 |
Consolidated Net Profit | 50 | -242 | 250 | -733 |
Adjusted EPS | --- | -1 | 1 | -3 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Share Capital | 224 | 224 | 224 | 224 |
Total Reserves | 10468 | 10422 | 10655 | 10396 |
Minority Interest | --- | --- | --- | --- |
Total Non-Current Liabilities | 1415 | 2131 | 2963 | 1264 |
Total Liabilities | 21836 | 21686 | 23880 | 23758 |
Capital Work in Progress | 658 | 778 | 851 | 986 |
Total Assets | 21836 | 21686 | 23880 | 23758 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Cash Flow from Operating Activities | 2247 | 1337 | 950 | 214 |
Cash Flow from Investing Activities | -170 | 517 | 166 | -286 |
Cash Flow from Financing Activitie | -2054 | -1856 | -1194 | 115 |
Net Cash Inflow / Outflow | 22 | -2 | -77 | 42 |
Nectar Lifesciences
39.5-0.6 (-1.6%)
Symbol | Change% |
---|---|
INDOUS | 328.05(20%) |
SAURASHCEM | 125.29(19%) |
GALAPREC | 1353.05(18%) |
INTELLECT | 1051.9(15%) |
TAJGVK | 402.95(14%) |
Announcing Stock of the Month!